Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Nonhematological Malignancies”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Early research (Phase 1)Ended earlyNCT03370302
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of TAK-228 as Single Agent in Adult East Asian Participants With Advanced Nonhematological Malignancies

Who this might be right for
Advanced Nonhematological Neoplasms
Calithera Biosciences, Inc 28
Early research (Phase 1)Study completedNCT00831896
What this trial is testing

Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies

Who this might be right for
Advanced Solid Tumors
Millennium Pharmaceuticals, Inc. 27
Testing effectiveness (Phase 2)Study completedNCT01045421
What this trial is testing

Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

Who this might be right for
Advanced Nonhematological MalignanciesNon-Small Cell Lung CancerSmall Cell Lung Cancer+3 more
Millennium Pharmaceuticals, Inc. 273
Early research (Phase 1)Ended earlyNCT01179399
What this trial is testing

Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic Malignancies

Who this might be right for
Advanced Nonhematological Malignancies
Millennium Pharmaceuticals, Inc. 32